NDAQ:SNGX - Post Discussion
Post by
borrock on Nov 25, 2020 2:30pm
Future trend
| ZACKS SCR IS BULLISH ON SOLIGENIX, SUGGESTING 580% UPSIDE; MULTIPLE ASSETS COMBINE TO SET UP THREE NEAR-TERM POTENTIAL CATALYSTS |
Soligenix (NASDAQ: SNGX) is earning Zacks SCR analysts’ confidence, who prescribe a 12-month price target of $15 per share. A rise in that magnitude represents a more than 580% increase from its current trading price*. Several reasons combine to justify the lofty valuation. (*share price and percentage calculation as of 11:00ET 11/23/20) |
Be the first to comment on this post